240 related articles for article (PubMed ID: 21506975)
1. Leprosy in the Philippines: a review.
Handog EB; Gabriel MT; Co CC
Int J Dermatol; 2011 May; 50(5):573-81. PubMed ID: 21506975
[TBL] [Abstract][Full Text] [Related]
2. [Leprosy - a neglected disease].
Schenk M
Dtsch Med Wochenschr; 2015 Apr; 140(9):698-9. PubMed ID: 26120615
[No Abstract] [Full Text] [Related]
3. An update on the diagnosis and treatment of leprosy.
Moschella SL
J Am Acad Dermatol; 2004 Sep; 51(3):417-26. PubMed ID: 15337986
[No Abstract] [Full Text] [Related]
4. Second coming: the re-emergence and modernization of immunotherapy by vaccines as a component of leprosy control.
Duthie MS; Casper C; Reed SG
Future Microbiol; 2018 Oct; 13():1449-1451. PubMed ID: 30311780
[No Abstract] [Full Text] [Related]
5. Leprosy and the rhetoric of elimination.
Khan Burki T
BMJ; 2013 Oct; 347():f6142. PubMed ID: 24141886
[No Abstract] [Full Text] [Related]
6. Disabilities in multibacillary leprosy following multidrug therapy with and without immunotherapy with Mycobacterium w antileprosy vaccine.
Sharma P; Kar HK; Misra RS; Mukherjee A; Kaur H; Mukherjee R; Rani R
Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):250-8. PubMed ID: 10575404
[TBL] [Abstract][Full Text] [Related]
7. The frequency of drug resistance mutations in Mycobacterium leprae isolates in untreated and relapsed leprosy patients from Myanmar, Indonesia and the Philippines.
Matsuoka M; Budiawan T; Aye KS; Kyaw K; Tan EV; Cruz ED; Gelber R; Saunderson P; Balagon V; Pannikar V
Lepr Rev; 2007 Dec; 78(4):343-52. PubMed ID: 18309708
[TBL] [Abstract][Full Text] [Related]
8. Current status of leprosy: epidemiology, basic science and clinical perspectives.
Suzuki K; Akama T; Kawashima A; Yoshihara A; Yotsu RR; Ishii N
J Dermatol; 2012 Feb; 39(2):121-9. PubMed ID: 21973237
[TBL] [Abstract][Full Text] [Related]
9. Time to define leprosy elimination as zero leprosy transmission?
Smith CS; Aerts A; Kita E; Virmond M
Lancet Infect Dis; 2016 Apr; 16(4):398-9. PubMed ID: 27036335
[No Abstract] [Full Text] [Related]
10. Leprosy.
Sugita Y
Clin Dermatol; 1995; 13(3):235-43. PubMed ID: 8521365
[No Abstract] [Full Text] [Related]
11. Primary multidrug-resistant leprosy, United States.
Williams DL; Hagino T; Sharma R; Scollard D
Emerg Infect Dis; 2013 Jan; 19(1):179-81. PubMed ID: 23260417
[No Abstract] [Full Text] [Related]
12. Neurological manifestations of Hansen's disease and their management.
Agrawal A; Pandit L; Dalal M; Shetty JP
Clin Neurol Neurosurg; 2005 Oct; 107(6):445-54. PubMed ID: 16202816
[TBL] [Abstract][Full Text] [Related]
13. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts.
Torres P; Camarena JJ; Gomez JR; Nogueira JM; Gimeno V; Navarro JC; Olmos A
Lepr Rev; 2003 Mar; 74(1):18-30. PubMed ID: 12669929
[TBL] [Abstract][Full Text] [Related]
14. Metagenomics of Imported Multidrug-Resistant Mycobacterium leprae, Saudi Arabia, 2017.
Guan Q; Almutairi TS; Alhalouli T; Pain A; Alasmari F
Emerg Infect Dis; 2020 Mar; 26(3):615-617. PubMed ID: 32091380
[TBL] [Abstract][Full Text] [Related]
15. Leprosy: a review on elimination, reducing the disease burden, and future research.
Chaptini C; Marshman G
Lepr Rev; 2015 Dec; 86(4):307-15. PubMed ID: 26964426
[TBL] [Abstract][Full Text] [Related]
16. The source of infection: an unsolved issue.
Lechat MF
Indian J Lepr; 2000; 72(2):169-73. PubMed ID: 11008657
[No Abstract] [Full Text] [Related]
17. Screening of drugs for activity against Mycobacterium leprae.
Baohong J; Matsuo Y; Colston MJ
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):836-42. PubMed ID: 3325576
[No Abstract] [Full Text] [Related]
18. Leprosy now: epidemiology, progress, challenges, and research gaps.
Rodrigues LC; Lockwood DNj
Lancet Infect Dis; 2011 Jun; 11(6):464-70. PubMed ID: 21616456
[TBL] [Abstract][Full Text] [Related]
19. Leprosy at a turning point?
Harboe M
Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095
[No Abstract] [Full Text] [Related]
20. Primary dapsone resistance in Cebu, The Philippines; cause for concern.
dela Cruz E; Cellona RV; Balagon MV; Villahermosa LG; Fajardo TT; Abalos RM; Tan EV; Walsh GP
Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):253-6. PubMed ID: 8862258
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
